drugset / Trial / NCT04459273
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
NaSingle-groupOpen-labelBasic science
Summary
This exploratory study investigates how an imaging technique called 68Ga-FAPi-46 PET/CT can determine where and to which degree the FAPI tracer (68Ga-FAPi-46) accumulates in normal and cancer tissues in patients with cancer. Because some cancers take up 68Ga-FAPi-46 it can be seen with PET. FAP stands for Fibroblast Activation Protein. FAP is produced by cells that surround tumors (cancer associated fibroblasts). The function of FAP is not well understood but imaging studies have shown that FAP can be detected with FAPI PET/CT. Imaging FAP with FAPI PET/CT may in the future provide additional information about various cancers.
Timeline
- Start
- 2020-08-27
- Primary completion
- 2025-06-24
- Completion
- 2027-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FAPI-46 GA-68 | Diagnostic / imaging agent | — | Intravenous |
Indications
adrenal gland cancer
brain cancer
cancer of unknown primary site
cervical carcinoma
cholangiocarcinoma
hematopoietic and lymphoid cell neoplasm
hepatocellular carcinoma
neuroendocrine neoplasm
pleural cancer
skin cancer
testicular cancer
thymus cancer
thyroid gland carcinoma
urinary bladder carcinoma
urothelial carcinoma